Plasma hormone changes during infusions of prostaglandins F2alpha and E2 for therapeutic abortion.
D000028:Abortion, Induced; D000293:Adolescent; D000328:Adult; D002584:Cervix Uteri / Q000187:drug effects; D006063:Chorionic Gonadotropin / Q000097:blood; D002850:Chromatography, Gel; D004958:Estradiol / Q000097:blood; D004964:Estriol / Q000097:blood; D004970:Estrone / Q000097:blood; D005260:Female; D006728:Hormones / Q000097:blood*; D006801:Humans; D006828:Hydatidiform Mole; D006854:Hydrocortisone / Q000097:blood; D006908:Hydroxyprogesterones / Q000097:blood; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011374:Progesterone / Q000097:blood; D011453:Prostaglandins / Q000627:therapeutic use*; D011458:Prostaglandins E / Q000627:therapeutic use; D011460:Prostaglandins F / Q000627:therapeutic use; D011485:Protein Binding
D006063:Chorionic Gonadotropin; D006728:Hormones; D006908:Hydroxyprogesterones; D011453:Prostaglandins; D011458:Prostaglandins E; D011460:Prostaglandins F; D004970:Estrone; D011374:Progesterone; D004958:Estradiol; D004964:Estriol; D006854:Hydrocortisone